NORMIA® stručne reference

1. Kalliomäki, M., Probiotics in primary prevention of atopic disease. A randomised placebo-controlled trial, The lancet, Vol 357, April 7, 2001.
2. Kalliomäki, M., Probiotics and prevention of atopic disease: 4-year follow up of a randomised placebo-controlled trial, The Lancet, Vol 361, May 31, 2003.
3. Huurre, A., Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization, Clin Exp Allergy, 2008., 38(8),1342.–1348.
4. Kalliomäki, M. et al, Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial, J Allergy Clin Immunol, 2007., 119(4)., 1019.–1021.
5. Isolauri, E., Probiotics in the managemant of atopic eczema, Clinical and Experimental Allergy, 2000., vol. 30.;1604.–1610.
6. Pohjavuori, E., Lactobacillus GG® effect in increasing IFN–γ production in infants with cow´s milk allergy, J Allergy Clin immunol, 2004., Vol. 114.,1.
7. Majamaa, H., Probiotics: A novel approach in the managemant of food allergy, J Allergy Clin immunol, 1996., Vol. 99., 2.
8. Michail, S. et al, Efficacy of probiotics in treatment of pediatric atopic dermatitis a meta-analysis of randomized, controlled trials, 2008., 101(5), 508.–516.
9. Ouwehand, A.C., The mucus binding of Bifidobacterium lactis BB-12 is enhanced in the presence of Lactobacillus GG®, Letters in Applied Miscrobiolo
10. Pirkka, V., The ability of probiotic bacteria to bind to human intestinal mucus, FEMS, 167., 1998., 185.–189.